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ABSTRACT
The aim of this study was to develop and validate a simple and compact bioreactor system for perfusion
cell seeding and culture through 3-dimensional porous scaffolds. The developed Tissue Culture Under
Perfusion (T-CUP) bioreactor is based on the concept of controlled and confined alternating motion of
scaffolds through a cell suspension or culture medium, as opposed to pumping of the fluid through the
scaffolds. Via the T-CUP, articular chondrocytes and bone marrow stromal cells could be seeded into po-
rous scaffolds of different compositions and architectures (chronOS, Hyaff -11, and Polyactive) at
high efficiency (greater than 75%), uniformity (cells were well distributed throughout the scaffold pores),
and viability (greater than 97%). Culture of articular chondrocytes seeded into 4-mm thick Polyactive
scaffolds for 2 weeks in the T-CUP resulted in uniform deposition of cartilaginous matrix. Cultivation of
freshly isolated human bone marrow nucleated cells seeded into ENGipore ceramic scaffolds for 19 days
in the T-CUP resulted in stromal cell-populated constructs capable of inducing ectopic bone formation in
nude mice. The T-CUP bioreactor represents an innovative approach to simple, efficient, and reliable 3D
cell culture, and could be used either as a model to investigate mechanisms of tissue development or as a
graft manufacturing system in the context of regenerative medicine.
INTRODUCTION
THE ABILITY to cultivate cells reliably in a 3-dimensional(3D) environment is an important step for the devel-
opment of physiological in vitro models to investigate
mechanisms of cell growth, differentiation, and tissue de-
velopment, as well as for the generation of implantable tis-
sue constructs in the context of regenerative medicine.
Approaches employing cell seeding and culture within po-
rous 3D scaffolds are now commonplace; however, typical
methodologies and technologies suffer from several limita-
tions, especially if the target construct is a few millimetres in
thickness.
Under static conditions it is generally difficult to dis-
tribute cells within the scaffold with adequate efficiency
and uniformity, and subsequently supply them with suffi-
cient nutrients to support growth,1–5 function, and viability
throughout the full thickness of the construct.2,3,5–7. Stirred
systems represent an improvement as compared to static
cultures,2,3,8 but uniform cell distributions remain difficult
to be achieved,3,9 and mass transfer limitations continue to
restrict the thickness of tissue that can be generated.8–10 In
addition, low cell seeding efficiencies have been reported
using static or stirred cultures2,6,11,12: this is a critical is-
sue for many tissue engineering applications, where only
a limited amount of cells is available. Relatively uniform
distributions of extracellular matrix were achieved by ap-
plication of dynamic laminar flow within Rotary Cell Cul-
ture Systems (RCCS).13 While in this approach diffusion
restrictions are relaxed and good mixing is achieved, the
RCCS is not well suited for cell seeding into porous scaf-
folds, and construct size is ultimately still diffusion limited.
To overcome the limitations of static and stirred culti-
vation systems, direct perfusion through the scaffold pores
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of a cell suspension for cell seeding, and of culture medium
for subsequent culture, is becoming increasingly popular.
Direct perfusion systems have been reported to achieve high
cell seeding efficiencies at uniform distributions, maintain-
ing cell viability within large constructs for extended peri-
ods of time.14–18 Flow-induced shear stresses in perfusion
systems were also used to improve osteoprogenitor cell
proliferation and differentiation,19 and to study fundamental
aspects of tissue development in vitro in the presence of
controlled physical conditioning.20 However, existing per-
fusion bioreactor systems tend to be complicated in design,
difficult to operate, inflexible, or inefficient. Complicated
pump and tubing arrangements, unreliable connectors and
fittings, fixed geometries, limited capacity, and the need for
skilled operators to reduce the risk of leaking and contam-
ination are among a number of limitations, related to the
need of moving fluid through fixed paths.
It occurred to us that a simplified perfusion reactor con-
figuration, possibly overcoming such limitations, could be
based on an alternative principle, whereby scaffolds are
moved through the fluid, as opposed to the fluid being
pumped through the scaffolds. Thus, the aim of this study
was to develop and validate a bioreactor for perfusion cell
seeding and culture through 3D porous scaffolds, based on
the concept of controlled motion of scaffolds through a cell
suspension or culture medium. The performance of such a
system was assessed with regard to cell seeding efficiency
and uniformity, operational reliability, support and main-
tenance of viable cell populations over extended culture pe-
riods, and ability to generate uniform tissue constructs of
clinically relevant size (i.e., a fewmillimeter thickness), using
a variety of scaffold compositions and pore architectures.
MATERIALS AND METHODS
Scaffolds and scaffold preparation
We used scaffolds of various compositions and architec-
tures. Polyactive foams (IsoTis N.V., NL) were made of
poly(ethylene glycol terephthalate) (PEGT):poly(butylene
terephthalate) (PBT) in a ratio of 55:45, with 300MWPEGT
and a porosity of 75%. Hyaff-11 nonwoven meshes (Fidia
Advanced Biopolymers, Italy) were made of esterified hy-
aluronic acid, with a porosity of 93%. ChronOS (Synthes,
CH) and ENGipore (Fin-Ceramica Faenza, I) ceramic foams
were made of respectivelyb-tricalcium phosphate, with a po-
rosity of 60%, and hydroxyapatite, with a porosity of 83%.
Polyactive, Hyaff-11, ChronOS, and ENGipore
scaffolds were used as 4mm thick8mm diameter cylin-
ders. ChronOS scaffolds were also available in the form
of granules (1.4–2.4mm). Polyactive scaffolds were ster-
ilized and hydrated via graded ethanol concentrations in
milliQ water, followed by overnight soaking in culture me-
dium. All other scaffolds were available presterilized from
the manufacturer.
Cell isolation and culture medium
Bovine articular chondrocytes (AC). Femoral condyle
cartilage of bovine calves was digested for 22 h in 0.15%
type II collagenase (Worthington) at 378C. Isolated cells
were plated overnight on tissue culture plastic in high-
glucose Dulbecco’s modified Eagle’s medium (DMEM; In-
vitrogen) with typical culture supplements (i.e., 10% fetal
bovine serum [FBS], 1mM sodium pyruvate, 10mM N-2-
hydroxyethylpiperazine-N0-2-ethanesulfonic acid (HEPES),
2mM L-glutamine, 100U/mL of penicillin, and 100 mg/mL
of streptomycin, all from Invitrogen), and subsequently stored
in liquid nitrogen. AC were expanded for a maximum of 6
passages in the above medium further supplemented with
1 ng/mL transforming growth factor-b (TGFb-1; R&D Sys-
tems Europe) and 5 ng/mL of fibroblast growth factor-2
(FGF-2; R&D Systems Europe), as previously described.21
The same medium was used during bioreactor culture.
Human bone marrow stromal cells (BMSC). Bone mar-
row aspirates were obtained from the iliac crest of healthy
patients during routine orthopaedic surgical procedures, in
accordance with local ethical regulations and with informed
patient consent. Nucleated cells were isolated by Histopa-
que (Sigma) density centrifugation and then either plated
onto tissue culture plastic (for expansion before seeding ex-
periments), or transferred directly to the bioreactor. Cells
for seeding experiments were expanded for a maximum of
5 passages in medium consisting of a-minimum essential
medium (a-MEM) with the above defined culture supple-
ments to which 5 ng/mL of FGF-2 were further added.
The Tissue-Culture Under Perfusion (T-CUP)
bioreactor
The T-CUP bioreactor employs the principle of alter-
nating perfusion15 to distribute cells within scaffolds and
maintain nutrient supply. A peculiar feature of the system is
the fact that perfusion is generated by the motion of scaf-
folds through the fluid (i.e., a cell suspension or culture
medium), with the only possible path for the fluid being
through the scaffold pores.
In the assembled bioreactor, scaffolds (Fig. 1a) were lo-
cated in a scaffold housing of customizable geometry fab-
ricated from polytetrafluoroethylene (PTFE) (Figs. 1b and
5a), which was mounted into a dual-upper reactor cup, made
of stainless steel (SS316L) (Fig. 1c). Unless otherwise stated,
the scaffold housing was made to accommodate 6 scaffolds
in the shape of 8mm diameter4mm thick cylinders. In
some experiments, the scaffold housing was in the form of
a basket, in which granular porous scaffolds were irregularly
compacted. The dual-upper cup was mounted over the lower
cup, also made of stainless steel (Fig. 1d), creating a closed
chamber that was dynamically sealed with an O-ring
(Fig. 1e). Internal surfaces were either coated with a 30-mm
layer of fluoroethylene propylene (FEP) or electropolished
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to ensure that cells would not adhere to the bioreactor and to
improve cleanability. FEP coating or electropolishing were
selected after preliminary experiments made with other ma-
terials, which either did not prevent cell attachment (i.e.,
polycarbonate, polysulfone) or were progressively deformed
by repeated autoclaving (i.e., PTFE, polyetheretherketone).
The interface region between the two reactor cups and the
dynamic seal was isolated from the external environment by a
flexible bellows (not shown in Fig. 1). The assembled reactor
vessel was mounted into a drive frame to which a stepper
motor was attached (L4218L1806-M6X1, Nanotec GmbH &
Co. KG, Munich), and by means of the drive interface (Fig.
1f ), the drive shaft was affixed to the top of the upper reactor
cup. A fully assembled system is shown in Fig. 2.
On operation of the stepper motor, the upper reactor cup
is driven along its vertical axis in alternating directions. Con-
sequently, scaffolds located in the scaffold housing move
through the fluid (i.e., cell suspension or culture medium) in
the lower cup, which is forced to pass through the pores of the
scaffolds. In particular, on the downward stroke compression
pushes medium through the pores, and on the upward stroke
expansion of the chamber reverses the flow direction (see
Fig. 3). Gas exchange occurs as a consequence of this cyclic
compression and expansion via a port on the dual-upper cup
fitted with a 0.2-mm sterile PTFE filter (Acro37, PALL).
Seeding uniformity
The bioreactor vessel was sterilized by autoclaving, and
assembledwith sterile scaffolds in a biological safety cabinet.
Twenty-five to thirty-five milliliters of seeding cell suspen-
sion at the desired density (typically in the range of 1106
1107 cells/scaffold) were introduced into the lower re-
actor cup, and the reactor vessel was then assembled and
mounted in the drive frame. The reactor was operated for
approximately 15 h at velocities from 0.1 to 3mm/s, after
which 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) solution was added to a final concentration
of 0.05mg/mL and perfused for a further 3 h. Scaffolds were
FIG. 1. Cross section of T-CUP bioreactor. (a) Scaffold, (b) scaf-
fold housing, (c) dual upper cup assembly, (d) lower cup assem-
bly, (e) O-ring, (f) drive shaft interface.
FIG. 2. Fully assembled T-CUP bioreactor vessel and drive unit.
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recovered, cut in half, and visually inspected for the distri-
bution of the blue/purple product of MTT reduction. The
reactor was operated at 378C in a humidified 5% CO2 cell
culture incubator.
Seeding efficiency and cell viability
To assess seeding efficiency, after 15 h of operation as
described above, scaffolds were retrieved from the biore-
actor, rinsed with phosphate-buffered saline (PBS), blotted
on tissue paper, and digested overnight in proteinase K so-
lution (1mg/mL of proteinase K, 50mM Tris, 1mM EDTA,
1mM iodoacetamide, Sigma), along with reference samples
of the initial cell suspension, containing known cell num-
bers. All samples were analyzed via the CyQUANT Cell
Proliferation Assay Kit (Molecular Probes). Cell seeding
efficiencies were calculated as the percentage of nucleic
acid in the scaffolds relative to the amount of nucleic acid
for the total number of cells loaded per scaffold.
Cellular viability within constructs following the seeding
phase, or after an additional 19 days of culture in the T-CUP,
was assessed using a Live/Dead Viability/Cytotoxicity Kit
from Molecular Probes. Scaffolds were perfused with 0.3%
collagenase solution for 45min, followed by perfusion with
0.05%–0.53mM trypsin–EDTA solution for a further 15min.
Cells were recovered by centrifugation and labeled with 4mM
ethidium homodimer-1 and 2mM calcein AM in PBS. Live
(green fluorescence) and dead (red fluorescence) cell popu-
lations were determined using a FACSCalibur (Beckton
Dickinson) flow cytometer. Gates were set using cells from a
freshly trypsinized monolayer culture as a ‘‘live cell control,’’
and cells from the same culture after incubation in 70%
ethanol for 30min as a ‘‘dead cell control.’’
Generation of cartilaginous constructs
Expanded bovine AC were transferred to the T-CUP and
cultured within Polyactive scaffolds for 14 days (drive
velocity of 1mm/s for the seeding phase, and of 0.4mm/s
for the culture phase), in DMEM with the above defined
culture supplements to which was added 10 ngmL of TGF-
b3, 10 mg/mL of insulin, and 0.1mM L-ascorbic acid-2-
phosphate, as previously described.22 Medium refreshment
was after 3 days and twice a week thereafter. Constructs were
then recovered, fixed, and paraffin embedded. Five-micron
sections were stained with safranin O for sulfated glycosami-
noglycans (GAG).
Generation of osteoinductive grafts
Freshly isolated bone marrow mononuclear cells were
transferred to the T-CUP and cultured within hydroxyapatite
ENGipore scaffolds for 19 days (drive velocity for seeding
1mm/s and 0.4mm/s during the culture phase), ina-MEM
with the above defined culture supplements to which was
added 5 ng/mL of FGF-2, 10 nM dexamethasone, and 0.1mM
L-ascorbic acid-2-phosphate, as previously described.17 Me-
dium was changed after 5 days and twice a week thereafter.
Constructs were then recovered and implanted ectopically
into nude mice for a further 8 weeks. Explanted tissues were
fixed overnight in formalin, decalcified, and paraffin em-
bedded for histological sectioning. Ten-micron sections were
stained with Mayer’s hematoxylin and eosin Y.
Statistics
Numerical data are presented as the mean standard er-
dard error of the mean. Unless otherwise stated, seeding ef-
ficiencies and viability were determined for a minimum of
5 scaffolds for each data point.
RESULTS
Technical operation of the T-CUP bioreactor
The T-CUP bioreactor allowed controlled perfusion of
a cell suspension or culture medium directly through the
scaffold pores. The velocity of the scaffolds that could be
achieved, driven by the stepper motor, was in the range
of 0.05mm/s to 7mm/s, with a step size resolution of
0.005mm. Velocity profiles could be defined via a PC in-
terface, thus allowing for a variety of perfusion regimens
to be applied. Operational reliability of the bioreactor was
tested in the context of long-term cultures for up to 21
days. These were conducted on multiple occasions with-
out mechanical failure, medium leaking, or contamination.
Cell seeding efficiency, uniformity, and cell viability
We first aimed at determining a suitable perfusion regimen
for seeding bovine AC into Polyactive scaffolds (Fig. 4a).
A drive velocity of 0.1mm/s resulted in poor seeding effi-
ciencies, with most cells settled at the T-CUP bottom. A ve-
locity increase to 1mm/s enhanced the cell seeding efficiency,
FIG. 3. Perfusion of medium through porous scaffolds in the
T-CUP bioreactor is induced by movement of the scaffolds through
the bulk medium. On the down stroke, medium is forced up through
the scaffold pores. On the up stroke the direction of perfusion is
reversed.
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but cells were still found at the bottom of the vessel. A further
velocity increase to 3mm/s resolved the issue of cell settling
but did not improve cell seeding efficiencies, likely owing to
shear stress-induced cell damage. A ramped velocity profile
was then tested to (1) prevent sedimentation of cells by
generation of a mixing effect and (2) minimize cell damage
due to continuous high-velocity flow: the drive velocity, set
at 1mm/s, was increased to 3mm/s when the scaffold hous-
ing approached the bottom of the culture vessel (i.e., starting
at a 4mm relative distance, corresponding to about 1 s out
of a cycle time of about 20 s), and then returned to 1mm/s.
This regimen resulted in reproducibly higher cell seeding
efficiencies (Fig. 4a). Using the same velocity profile for
other scaffold/cell type combinations, cell seeding efficien-
cies were always in excess of 75% (Fig. 4b), and cell viability
within the scaffolds, as assessed following enzymatic ex-
traction of the seeded cells, remained higher than 97%. Im-
portantly, cell seeding of the 6 individual constructs in the
same experimental run was highly reproducible, with stan-
dard deviations for seeding efficiencies in the replicate scaf-
folds averaging 6.2% 2.9%.
MTT labeling of seeded Polyactive and Hyaff-11
cylinders resulted in uniform staining (Fig. 5b and c), in-
dicating a uniform distribution of viable cells. ChronOS
cylinders displayed a relatively less uniform cell distribu-
tion, although cells were well dispersed throughout the
scaffold (Fig. 5d). The T-CUP bioreactor also allowed seed-
ing of porous granules or fragments, using a basket config-
uration of the scaffold housing (Fig. 5e). Assessment of cell
distribution indicated that for chronOS granules (Fig. 5f ),
all granules contained cells, although in larger granules a
cell-free core was often observed. As for cylinders, a more
uniform cell distribution was observed for Polyactive
fragments (Fig. 5g), with cells penetrating to the core.
Cartilaginous constructs
To assess the potential of the T-CUP system to support
cell differentiation, matrix deposition, and tissue maturation,
Polyactive scaffolds seeded with bovine articular chon-
drocytes (AC) were further cultured under perfusion for a
total of 14 days. The resulting tissues displayed abundant
extracellular matrix rather uniformly distributed and posi-
tively stained for GAG (Fig. 6a). AC, which during expan-
sion are known to de-differentiate, leading to a fibroblastic
phenotype and elongated morphology, displayed in the
generated tissues evidences of redifferentiation, with a typi-
cal spherical morphology and abundant pericellular matrix
(Fig. 6b).
FIG. 5. Scaffold housing for (a) disc-shaped scaffolds or
(e) granules/fragments, andMTT-labeled scaffolds after 15-h seed-
ing of bovine articular chondrocytes into (b) Polyactive discs,
(c) Hyaff-11 discs, (d) chronOS discs, (e) chronOS granules,
and (f) Polyactive fragments in the T-CUP bioreactor. Purple/
blue color corresponds to the presence of viable cells. Scale bar
is approximately 2mm. Color images available online at www
.liebertpub.com/ten.
FIG. 4. Cell seeding efficiencies in the T-CUP bioreactor (a)
using bovine articular chondrocytes (AC) and Polyactive foams
at different velocity regimens, or (b) using different combinations
of bovine AC and human bone marrow stromal cells (BMSC) on
Polyactive, Hyaff-11, or chronOS disc-shaped scaffolds at the
‘‘Ramp 1.0–3.0’’ regimen (corresponding to a cyclic increase of
the velocity from 1.0 to 3.0mm/s when the scaffold housing ap-
proaches the bottom of the vessel; see Results for a more detailed
description).
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Osteoinductive grafts
We next investigated whether the T-CUP bioreactor
would allow generation of osteoinductive grafts by direct
perfusion of bone marrow nucleated cells through ceramic
scaffolds, according to a recently described method which
bypasses bone marrow stromal cell (BMSC) expansion in
monolayer.17 Freshly isolated bone marrow cells were
seeded and cultured for 19 days within ENGipore scaffolds
under perfusion, resulting in the attachment and expansion
of viable BMSC (84.5% 0.2% viability) directly within
the scaffolds. After ectopic implantation of the generated
constructs into nude mice, bone tissue formation was ob-
served throughout the constructs in the form of typical
‘‘ossicles,’’ indicating the osteoinductive property of the
grafts (Fig. 7).
DISCUSSION
While direct perfusion is a promising approach to the
seeding of cells onto 3D scaffolds and subsequent cultivation,
there is a lack of simple, reliable, and efficient perfusion
bioreactor systems with the flexibility to easily accommodate
various scaffold types, geometries, and volumes.We have de-
veloped a simple to use bioreactor system, the T-CUP, that
generates perfusion by movement of 3D scaffolds through a
cell suspension or culture medium, and herein demonstrated
that it is efficient, flexible, reliable, and effective.
The proposed bioreactor design offers several advantages
over existing perfusion systems. First, the simple geometry
of the T-CUP allows for rapid assembly and disassembly,
with minimal risk of leakage resulting from a rarity of fit-
tings. Second, by employing a stepper motor to drive scaf-
folds through the medium, precise control of the perfusion
regimen can easily be achieved, whereas commonly used
peristaltic pumps are prone to changing performance over
time as tubes wear and stretch. The stepper motor also of-
fers the possibility of tightly controlled ramped or stepped
profiles and combinations of perfusion velocities, allowing
for optimized cell/tissue-specific regimens with the same
system. The importance of this feature was demonstrated in
the phase of cell seeding, to reach reproducibly high seeding
efficiencies. Third, the flexible configuration of the scaffold
housing can accommodate scaffolds in a variety of numbers,
sizes, and shapes with minimal changes in the system. The
scaffold housing could allocate 6 discs, allowing reproduc-
ible replicate cultures in the same unit, could be made in
the shape of a basket, allowing seeding of granule-shaped
scaffolds, and indeed it could be entirely formed out of
FIG. 6. Representative safranin-O stained sections of Poly-
active scaffolds loaded with bovine articular chondrocytes and
cultured for 14 days in the T-CUP. Orange-red staining indicates
the deposition of cartilaginous matrix containing sulfated gly-
cosaminoglycans. The letter s indicates parts of the undegraded
scaffold. Scale bar¼ 400 mm (a) and 100mm (b). Color images
available online at www.liebertpub.com/ten.
FIG. 7. Representative H&E-stained section of ENGipore scaf-
folds loaded with human bone marrow nucleated cells, cultured for
19 days in the T-CUP, and implanted into nude mice for a further
8 weeks. Bone tissue (b) formation is apparent from the densely
stained extracellular matrix observed within the scaffold (s) pores,
in contrast to fibrous (f ) or adipose (a) tissue. Scale bar¼ 100 mm.
Color images available online at www.liebertpub.com/ten.
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porous substrate, with—in the current T-CUP configuration—
a maximum diameter of 30mm and maximum length of
30mm. Fourth, the T-CUP bioreactor provides the opera-
tional advantage of cell seeding and subsequent culture into a
porous scaffold within the same reactor unit. A number of
previously described perfusion bioreactor systems employ
either static seeding of the scaffolds,23–29 or seeding in stirred
flasks,30,31 before transfer of the seeded scaffold to the per-
fusion system. This additional handling increases labor re-
quirements and the possibility of contamination. Alternative
systems to seed and culture cells into scaffolds under perfu-
sion require transit of cells across pump heads,10 which is
generally detrimental to cell viability, or decoupling the flow
paths of the seeding and culture phases,22 which is associated
with complicated settings and increased contamination risks.
Fifth, fluid flow through the scaffolds in the T-CUP bioreactor
is inherently dynamic (i.e., in alternate directions at each
cycle), as opposed to conventional steady-flow perfusion
systems. This feature could be crucial for more uniform
seeding and nutrition of cells in the scaffolds.
For human BMSC and bovine AC on several different
scaffold types, efficiencies of 75–86% (Fig. 4) were achieved
with the T-CUP bioreactor. This is comparable to the effi-
ciencies reported by Wendt et al.15 for a U-tube bioreactor
employing alternating perfusion. Cells seeded in the T-CUP
were distributed throughout cylindrical scaffolds (Fig. 5b–d),
with viability near 100%. The less uniform cell distribution
observed within chronOS cylinders was most likely a con-
sequence of scaffold architecture (e.g., relatively lower po-
rosity).
In the case of chronOS granules (Fig. 5f ), contact re-
gions between individual granules and random open chan-
nels throughout the packed material are likely causes of a
heterogeneous cell distribution. Considered as a whole, cells
were well distributed throughout, and changes to packing
and perfusion regimen are being investigated to improve
distribution, penetration of cells into larger granules, and
efficiency. Polyactive fragments seeded uniformly and
with full penetration of cells into the scaffold, suggesting
that fragments/granules of a more porous material might
perform well without the need for specific optimization.
With its ease of use and high efficiency, the T-CUP could
be an ideal bioreactor system for reliable and streamlined
manufacture of grafts for clinical use.14 As a proof that the
system can support cell differentiation, matrix deposition,
and tissue maturation in vitro, we generated uniform carti-
laginous tissues in a clinically relevant size (i.e., up to 4mm
thickness) starting from culture-expanded bovine articular
chondrocytes. Further, as a demonstration that the system can
streamline generation of tissues with the capacity to develop
in vivo, we engineered osteoinductive constructs from freshly
harvested human bone marrow cells, bypassing the phase of
monolayer expansion of the mesenchymal component, in one
single closed environment (Fig. 6). Further studies are re-
quired to investigate in the T-CUP system the effect of per-
fusion rate on cell differentiation and tissue growth, possibly
combining experimental data with computational fluid dy-
namic and mass transport models.32
The T-CUP is currently being developed as a stand-alone
system, with monitoring and control of relevant culture
parameters, and including the feature of automated medium
exchange, to provide a controlled and standardized ‘‘GMP
in a box’’ environment. This would find application for the
one-step manufacture of grafts starting from a patient biopsy
in the field of clinical tissue engineering or for the auto-
mated expansion of cells within a 3D environment, for use
in cell therapy and regenerative medicine. In its current con-
figuration, the T-CUP bioreactor is an inherently simple,
efficient, reliable, general- purpose system that can be used
as a model to investigate the function of a variety of cell
types in a 3D environment, using appropriate porous scaf-
folds as carriers.
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